Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stem (STEM) Receivables (2020 - 2025)

Historic Receivables for Stem (STEM) over the last 6 years, with Q3 2025 value amounting to $38.7 million.

  • Stem's Receivables fell 6118.64% to $38.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.7 million, marking a year-over-year decrease of 6118.64%. This contributed to the annual value of $67.1 million for FY2024, which is 8638.84% down from last year.
  • Latest data reveals that Stem reported Receivables of $38.7 million as of Q3 2025, which was down 6118.64% from $47.1 million recorded in Q2 2025.
  • Stem's 5-year Receivables high stood at $493.1 million for Q4 2023, and its period low was $18.0 million during Q2 2021.
  • In the last 5 years, Stem's Receivables had a median value of $97.9 million in 2022 and averaged $164.7 million.
  • Per our database at Business Quant, Stem's Receivables skyrocketed by 43967.87% in 2021 and then crashed by 8638.84% in 2024.
  • Stem's Receivables (Quarter) stood at $73.9 million in 2021, then surged by 406.7% to $374.5 million in 2022, then skyrocketed by 31.66% to $493.1 million in 2023, then crashed by 86.39% to $67.1 million in 2024, then plummeted by 42.28% to $38.7 million in 2025.
  • Its Receivables stands at $38.7 million for Q3 2025, versus $47.1 million for Q2 2025 and $42.4 million for Q1 2025.